[306 Pages Report] The global non-invasive surgical wound closure market is estimated to be valued at US$ 2,192.3 billion in 2022. This market is expected to grow at a CAGR of 4.1% over the forecast period (2022 to 2032) to reach a market size of US$ 3,404.6 billion by 2032. Earlier, during the historical period of 2017 to 2021, the market accounted CAGR of 3.2%.
The non-invasive surgical wound closure market is steadily expanding due to an increase in operations performed globally. The demand for aesthetic surgery is rising, and the trend away from invasive to non-invasive surgery choices is shifting as well, creating new opportunities for the use of non-invasive surgical wound closures that possibly will one day become successful enterprises. In the accident and emergency department, where there is a high patient volume, non-invasive procedures save doctors time. As a result, non-invasive surgical wound closures are in demand from a variety of customers.
In the upcoming years, prospects such as a significant rise in the number of skin closure product approvals and technical improvements are anticipated to drive the market's expansion. The market expansion is anticipated to be accelerated by a growing focus on minimally invasive surgical techniques. Also predicted to provide a beneficial environment for market expansion is the rising number of product approvals. Derma surgeons deal with a variety of wounds that need to be closed regularly. Therefore they require a technique that is both time and money effective.
Additionally, there are many different types of skin closure materials accessible due to the rise in cosmetic treatments. The market for non-invasive surgical wound closure is anticipated to experience tremendous development as a result of the rising demand for aesthetic procedures and the shift from invasive to non-invasive surgical treatments. There is a demand for aesthetic appeal since society has become increasingly mindful of appearance.
In addition to this, as the incidence of chronic wounds like diabetic foot ulcers, venous leg ulcers, and pressure ulcers rises, these devices are becoming tremendously popular since they reduce the risk or hazard of excessive scarring and infection. Demand for non-invasive surgical wound closure and closure devices is also rising as a result of efforts to cut back on hospital stays to lower surgical healthcare costs, as well as a growing preference for products that enhance therapeutic outcomes.
| Report Attribute | Details |
|---|---|
| Non-invasive Surgical Wound Closure Market Historical Growth Rate (2017 to 2021) | 3.2% |
| Non-invasive Surgical Wound Closure Market Value (2022) | US$ 2,192.3 billion |
| Non-invasive Surgical Wound Closure Market Anticipated Forecast Value (2032) | US$ 3,404.6 billion |
| Non-invasive Surgical Wound Closure Market Projected Growth Rate (2022 to 2032) | 4.1% |
For instance, the Independent Diabetes Trust in the UK stated in 2019 that around 115,000 people in the country get diabetic foot ulcers each year, and 278,000 people receive treatment for venous leg ulcers. The typical healing time for these ulcers is 200 days. The yearly incidence of diabetic foot ulcers ranges from 9.1 to 26.1 million worldwide, according to data released by the National Centre for Biotechnology Information (NCBI).
Market players are attempting to develop fresher surgical methods and technology. Any wound treatment or incision surgery can aim for fast closure with the development of an attractive and useful scar. Stitches were once the sole choice for closing wounds, but as the market became saturated, competitors began to create less invasive treatments like staples and adhesives like sticky tapes and glue.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Acute wounds, chronic wounds, and surgical wounds are just a few examples of physical health issues that have a negative effect on wound recovery. Over the past ten years, there has been a considerable increase in the prevalence of acute, chronic, and surgical wounds, mostly as a result of the increasing elderly population worldwide, rising traumatic wounds, budding surgery rates, and escalating rates of obesity and diabetes.
The number of people having cosmetic surgery is rising. The minimally invasive method also spares doctors' time in the accident and emergency department, where there is a high patient volume. Due to its many benefits, including shorter recovery times, decreased risk of infection, cheaper cost, instantaneous wound sealing, and a reduction in the risk of needle-related injuries, non-invasive wound closure is in great demand.
Government funding is increasing to upgrade the healthcare system. It is anticipated that there will be more hospitals and clinics over the projection period, which will result in a rise in the need for non-invasive surgical wound closure. The benefits of these closure devices, such as their great efficiency in ensuring safety, shorter recovery times, and accuracy, are what primarily drive adequate demand from customers. Non-invasive surgical wound closure is in high demand due to rising accident and sports injury rates, and this demand is expected to continue during the projection period.
The high cost of advanced wound closure devices and therapies for chronic wounds may limit their use, especially in cost-concerned nations of the Asia Pacific region. Patients and doctors select affordable wound closure procedures in these nations. Despite the abundance of bioengineered dressings in these locations, due to their affordability, traditional and basic wound closure techniques remain preferred by physicians and patients.
Principal Consultant
Considering the cost of healthcare, the growing demands for aesthetic surgery, and the greater amount of disposable income, North America holds the greatest revenue share for non-invasive surgical wound closure, which is close to 39.9%. The non-invasive surgical wound closure market in North America significantly contributes to the expansion of the global market. This fact is demonstrated by the increase in revenue of this region's top non-invasive surgical wound closure manufacturers. Additionally, the need for aesthetic procedures and high disposable income are fueling this region's industrial expansion.
Due to the increased attention that key market players are paying to enter this region's market, it is anticipated that this region will continue to hold sizable market shares during the projection period. This can be attributable to regionally strong established businesses with efficient distribution networks, as well as established reimbursement systems.
The USA is one of the world's biggest markets for wound closure technology. Customers' preference for painless treatments has been noticed to be in high demand in this area and is most likely to take the lead in manufacturing during the forecast period. The healthcare industry will drive demand for non-invasive surgical closures devices in the US and Canada. It is projected that the suitable sales increase over the forecast period would result from the growing government investment in the construction of healthcare infrastructure.
Nearly 30% of the market is also accounted for by Europe. This is attributable to a sizable patient pool suffering from lifestyle-associated diseases like diabetes and obesity, increasing government investment in enhancing healthcare infrastructure, growth in the demand for affordable and cutting-edge care in the region, growing awareness of minimally invasive surgical procedures, and growing propensity of physicians toward adoption of cutting-edge minimally invasive skin closure systems in post-surgical and wound care.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
As the wound closure market is extensively fragmented and competitive, new market entrants are experimenting with modern and updated technologies to invent different products. For instance, in February 2022, Evonik Venture Capital invested in CircumFix Solutions, a Tennessee-based start-up that created a novel high-performance polymer sternal closure device that effectively seals and stabilizes the sternum following surgery.
In order to stay competitive with other businesses in the field, the businesses are planning innovation, product releases, and collaborations. The noninvasive surgical wound closure industry is growing as key market participants consolidate their markets. To avoid delays in approvals, corporations make significant investments in compliance, research, and development. This is important for them to save on investments and achieve profitability.
Example:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 4.1% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global non-invasive surgical wound closure market is expected to progress at a CAGR of 4.1% (2022 to 2032).
North America is expected to hold the highest share (39.9%) in the global non-invasive surgical wound closure market.
Global non-invasive surgical wound closure market is predicted to account for US$ 3,404.6 million by 2032.
1. Executive Summary | Non-invasive Surgical Wound Closure Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032
5.3.1. Adhesive
5.3.2. Natural
5.3.3. Synthetic
5.3.4. Adhesive barrier products
5.3.5. Hemostats
5.3.6. Mechanical
5.3.7. Active
5.3.8. Flowable
5.3.9. Sealants
5.3.10. Fibrin
5.3.11. Surgical
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032
6.3.1. Orthopedics
6.3.2. Cosmetics
6.3.3. Obstetrics and Gynecology
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
7.3.1. Hospital
7.3.2. Clinics
7.3.3. Dermatological Clinical
7.3.4. Ambulatory Surgical Centers
7.3.5. Emergency Service Centers
7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. Middle East and Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. United States of America
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Product Type
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product Type
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. United States of America
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Product Type
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Product Type
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Product Type
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Product Type
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Product Type
16.5.2.2. By Application
16.5.2.3. By End User
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2021
16.6.2.1. By Product Type
16.6.2.2. By Application
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2021
16.7.2.1. By Product Type
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2021
16.8.2.1. By Product Type
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2021
16.9.2.1. By Product Type
16.9.2.2. By Application
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2021
16.10.2.1. By Product Type
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2021
16.11.2.1. By Product Type
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2021
16.12.2.1. By Product Type
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2021
16.13.2.1. By Product Type
16.13.2.2. By Application
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2021
16.14.2.1. By Product Type
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2021
16.15.2.1. By Product Type
16.15.2.2. By Application
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2021
16.16.2.1. By Product Type
16.16.2.2. By Application
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2021
16.17.2.1. By Product Type
16.17.2.2. By Application
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2021
16.18.2.1. By Product Type
16.18.2.2. By Application
16.18.2.3. By End User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2021
16.19.2.1. By Product Type
16.19.2.2. By Application
16.19.2.3. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2021
16.20.2.1. By Product Type
16.20.2.2. By Application
16.20.2.3. By End User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2021
16.21.2.1. By Product Type
16.21.2.2. By Application
16.21.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Advanced Medical Solutions Group Plc
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Ethicon Endo-Surgery, Inc
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Abbott Laboratories
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Baxter International Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Medtronic, Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. CP Medical, Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Aesculap AG & Co.KG
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Smith & Nephew
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Surgical Specialties Corporation
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Derma Sciences, Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Teleflex Medical OEM
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Zipline Medical, Inc
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Medi-zip GmbH
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. Takeda Pharmaceuticals International GmbH (Nycomed Pharma GmbH)
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.15. BSN Medical
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.16. 3M Corporation
18.1.16.1. Overview
18.1.16.2. Product Portfolio
18.1.16.3. Profitability by Market Segments
18.1.16.4. Sales Footprint
18.1.16.5. Strategy Overview
18.1.16.5.1. Marketing Strategy
18.1.17. Pro-Motion Medical B.V.
18.1.17.1. Overview
18.1.17.2. Product Portfolio
18.1.17.3. Profitability by Market Segments
18.1.17.4. Sales Footprint
18.1.17.5. Strategy Overview
18.1.17.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Non-invasive Surgical Wound Closure Market
